We evaluated several simple laboratory tests that have been used to identify pathogenic serotypes of Yersinia enterocolitica or to indicate the pathogenic potential of individual strains. A total of 100 strains of Y. enterocolitica were studied, including 25 isolated during five outbreak investigations, 63 from sporadic cases, and 12 from stock cultures. The pyrazinamidase test, which does not depend on the Yersinia virulence plasmid, correctly identified 60 of 63 (95% sensitivity) strains of pathogenic serotypes and 34 of 37 (92% specificity) strains of nonpathogenic serotypes. Salicin fermentation-esculin hydrolysis (25°C, 48 h) correctly identified all 63 (100%Y sensitivity) strains of the pathogenic serotypes and 34 of 37 (92% specificity) strains of the nonpathogenic serotypes. The results of the pyrazinamidase and salicin-esculin tests disagreed for only 7 of the 100 strains of Y. enterocolitica, and these would require additional testing. Congo red-magnesium oxalate (CR-MOX) agar determines Congo red dye uptake and calcium-dependent growth at 36°C, and small red colonies are present only if the strain contains the Yersinia virulence plasmid. This test has proven to be extremely useful for freshly isolated cultures, but only 15 of 62 strains of pathogenic serotypes that had been stored for 1 to 10 years were CR-MOX positive. None of the 16 strains of Y. enterocolitica serotype 03 fermented D-xylose, so this test easily differentiated strains of this serotype, which now appears to be the most common in the United States. Although antisera that can actually be used to serotype strains of Y. enterocolitica are not readily available, the four simple tests described above can be used to screen for pathogenic serotypes.
Since it was first described in 1939, Yersinia enterocolitica has become well established as an enteric pathogen (4-7). However, there is considerable confusion in the literature because not all strains of this species can cause intestinal infections. Unlike Salmonella and Shigella species, which are intrinsic pathogens (essentially all strains can cause enteric infections), there is strain-to-strain variation in the pathogenicity of Y enterocolitica (4, 6, 7, 12, 14, 19) . A number of studies have shown an excellent correlation between the serotype and biotype of Y enterocolitica and its ability to cause infections of the intestinal tract and to invade tissue (4, 6, 7, 12, 14, 21) .
Many different tests and methods have been used over the years to define the pathogenic potential of Y enterocolitica strains, but it has only recently been realized that an important component of virulence in this species is determined by a plasmid that is easily lost (10, 11, 19, 21) . For this reason, there is confusion in the literature on how well the various methods identify pathogenic serotypes and determine pathogenic potential.
In 1985, Kandolo and Wauters (10) described the pyrazinamidase test as a way of differentiating pathogenic from nonpathogenic serotypes of Y enterocolitica. In 1989, Riley and Toma (16) described Congo red-magnesium oxalate (CR-MOX) agar, a medium that allows easy recognition of Y enterocolitica colonies that contain the Yersinia virulence plasmid. This medium determines two properties that are plasmid dependent, Congo red dye uptake and calciumdependent growth at 36°C (see Fig. 1 ). In this report, we describe our experience with these two simple tests using strains isolated in the United States and show their correlation with serotype, salicin fermentation-esculin hydrolysis (salicin-esculin), and some other simple laboratory tests used to evaluate pathogenic potential (Table 1) .
MATERIALS AND METHODS
Nomenclature. In this report, we use the term "pathogenic serotype" to refer to 11 0-antigen groups of the Y enterocolitica serotyping schema. Strains belonging to these serotypes are generally recognized as being enteric pathogens on the basis of their occurrence in outbreaks and sporadic cases, pathogenicity in animal models, or the ability to invade tissue or animal cells in tissue culture (4, 6, 7, 14) . Strains of serotypes 03, 09, and 05,27 are well documented as enteric pathogens in humans and are the most important serotypes found in Europe and much of the rest of the world (4, 6, 7) . Until recently, these three serotypes were rare in the United States (2, 5, 13) , where the pathogenic serotypes 04,32; 08; 013a,13b; 018; 020; and 021 are usually found (2-6, 12, 13) . These six serotypes have been designated the pathogenic American serotypes (7, 10 (4, 7) . Serotype 01,2,3 has also been isolated from human clinical infections (16) .
Strains and stock cultures. The strains of Yersinia spp. studied are described in more detail in Tables 2 through 4 . Stock cultures were prepared at the time the culture was (10, (14) (15) (16) 20 (17) . A number of different serotypes, both pathogenic and nonpathogenic, were recovered during the outbreak investigations, but the majority from patients were serogroup 08 (data not shown). Outbreak 5 occurred during June and July 1982 in Tennessee, Arkansas, and Mississippi (18) and was due to Y enterocolitica 013a,13b that contaminated pasteurized milk.
Strains from sporadic cases, old stock cultures, and other Yersinia species. Strains from sporadic cases, old stock cultures, and other Yersinia species (see Table 3 ) included 63 consecutive isolates that were referred to the Enteric Diseases Laboratory for one of our diagnostic services (serotyping, serodiagnosis, identification, etc.). Ten stock cultures of strains from the culture collection of the International Yersinia Centre at the Institut Pasteur, Paris, France, were also included, because these were more than 10 years old and presumably had been transferred many times, making it likely that they had lost the Yersinia virulence plasmid. Two cultures of serotype 09 isolated in Belgium were also included. Serotype 09 is rarely, if ever, isolated in the United States. For comparison, some other Yersinia species were also studied (see Table 4 ).
Serotyping. The 0 antigen was determined by microtube agglutination in 96-well plastic plates or by slide agglutination (3, 4) . Absorbed sera were used when necessary. Strains that did not agglutinate in any of the sera used were coded NR, for no reaction. Strains that reacted in multiple sera were coded UND, for undefined. A few strains were rough and agglutinated in the saline control. All strains were defined as belonging to pathogenic or nonpathogenic serotypes on the basis of these serotyping results.
Tissue culture invasiveness. All 100 strains were tested at Stanford University for their ability to invade HEp-2 cells in culture (14) . Briefly, about 2 x 107 bacterial cells were added to a monolayer of HEp-2 cells in a 24-well plate. After several incubation and handling steps, the HEp-2 cells were lysed to release intracellular bacteria, which were then recovered and counted on plating media. The study of Miller et al. (14) also gives the results for the strains listed in Tables  1 to 3 that were obtained with several DNA probes designed to measure chromosomal virulence. Cell invasion appears to be independent of the Yersinia virulence plasmid and is coded by genes on the chromosome of Y enterocolitica (7, 14) . Strains of pathogenic serotypes (as defined by serotyping) were positive for cell invasion, as measured by a tissue culture assay and by DNA probe assays (14) , but (Table 5 ). Pyrazinamidase incorrectly identified strains of three pathogenic and three nonpathogenic serotypes. Salicin-esculin incorrectly identified strains of three nonpathogenic serotypes (Table 5 ). However, none of the nine strains were incorrectly identified by both the pyrazinamidase and the salicin-esculin tests. Both tests can be used routinely, and strains that provide conflicting results can be studied by other methods.
CR-MOX agar. Only 15 of the 63 strains of pathogenic serotypes produced small red colonies on CR-MOX agar. These results are in agreement with those of others (10, 12, 16, 19) , who have noted that strains that have been stored or subcultured several times have often lost the Yersinia virulence plasmid. After 24 to 30 h of incubation, it is usually possible to identify a pathogenic serotype and determine the percentage of the population (colonies) that still contains the plasmid (Fig. 1) .
Autoagglutination. Autoagglutination in MR-VP broth was easy to do and was easily adaptable to the daily routine since MR-VP broth is readily available in most laboratories. As with CR-MOX agar, old strains of pathogenic serotypes were usually negative. amidase and salicin-esculin tests were useful in differentiating pathogenic and nonpathogenic serotypes of Y enterocolitica, they should not be used until a strain has been identified to the species level. All strains of the other six Yersinia species were negative for tissue culture invasiveness and for the presence of the Yersinia virulence plasmid, as evidenced by their colonies on CR-MOX agar and lack of autoagglutination in MR-VP medium. These tests and many other reports indicate that strains of the six Yersinia species listed in Table 4 are not enteric pathogens (6, 7) . However, four strains had very weak pyrazinamidase reactions and might be read as negative (Table 4) . Nine strains were salicin-esculin negative, a property that is usually found in pathogenic serotypes of Y enterocolitica. Thus, biochemical testing is essential for differentiating these other Yersinia species from Y enterocolitica. Noble et al. (15) found that strains of some of the other Yersinia species had one or more properties perhaps suggestive of pathogenicity, but these results have not been confirmed. At present, there is no convincing evidence that strains of these other Yersinia species are enteric pathogens or are highly invasive for tissue. Further studies are needed to determine whether they have a role in human disease other than as opportunistic pathogens.
Until recently it has been very difficult for clinical and public health laboratories to determine the pathogenic potential of Y enterocolitica strains isolated from feces (1, 9 (6) . From the standpoint of clinical and public health, we do not consider strains of biogroup 1A to be enteric pathogens. This conclusion was based on (i) their widespread presence in the environment, (ii) their high isolation rate from healthy individuals and patients whose histories were not compatible with yersiniosis, (iii) lack of their recovery upon primary plating, regardless of source of isolation, and (iv) lack of antibody response in serum samples from 34 examined patients from whose stools a biogroup 1A strain had been isolated. Surprisingly 
